Brief: Century Therapeutics Announces Internal Portfolio Prioritization To Extend Cash Runway Into 2026

Century Therapeutics

05/01/2023 22:04

Jan 5 (Reuters) - Century Therapeutics Inc  IPSC.O :
    * CENTURY THERAPEUTICS ANNOUNCES INTERNAL PORTFOLIO
PRIORITIZATION
TO EXTEND CASH RUNWAY INTO 2026
    * CENTURY THERAPEUTICS INC - EMPLOYEE HEADCOUNT REDUCED BY
APPROXIMATELY 25 PERCENT, EXTENDING CASH RUNWAY INTO 2026
    * CENTURY THERAPEUTICS INC - PHASE 1 STUDY OF CNTY-101, IN
RELAPSED/REFRACTORY B-CELL LYMPHOMA REMAINS ON TRACK
    * CENTURY THERAPEUTICS INC - NO IMPACT TO PARTNERED PROGRAMS
WITH
BRISTOL MYERS SQUIBB
    * CENTURY THERAPEUTICS INC - AS RESULT OF OPERATIONAL
RESTRUCTURING, LAB OPERATIONS IN SEATTLE, HAMILTON WILL BE
CLOSED
    * CENTURY THERAPEUTICS INC - AS RESULT OF OPERATIONAL
RESTRUCTURING, RESEARCH ACTIVITIES WILL BE CONSOLIDATED IN
PHILADELPHIA

Source text for Eikon:  ID:nGNX63Mq0F 
Further company coverage:  IPSC.O 
 ((Reuters.Briefs@thomsonreuters.com;;))